Boothbay Fund Management, LLC Gossamer Bio, Inc. Transaction History

Boothbay Fund Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $28,000 - $63,001	58,335 New	58,335 $53,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $118,424 - $244,404	-16,425 Reduced 15.95%	86,541 $1.04 Million
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $181,882 - $303,746	30,466 Added 42.02%	102,966 $862,000
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $370,507 - $548,298	-43,899 Reduced 37.71%	72,500 $629,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $178,881 - $248,701	-17,676 Reduced 13.18%	116,399 $1.32 Million
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $228,048 - $416,149	31,455 Added 30.65%	134,075 $1.69 Million
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $17,320 - $21,108	2,165 Added 2.16%	102,620 $833,000
Q4 2020 Feb 12, 2021	BUY	$8.3 - $13.59 $426,943 - $699,056	51,439 Added 104.94%	100,455 $971,000
Q3 2020 Nov 16, 2020	SELL	$11.3 - $14.75 $120,989 - $157,928	-10,707 Reduced 17.93%	49,016 $608,000
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $568,562 - $954,373	59,723 New	59,723 $776,000
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $209,866 - $298,004	-13,019 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $228,874 - $312,065	13,019 New	13,019 $282,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $78.9M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.